Dianzani ALPS (RALD): A Patient Guide

Receiving a diagnosis of RAS-associated autoimmune leukoproliferative disease (RALD)—historically known as Dianzani ALPS—means entering a world of medical rarity. This guide is written primarily for parents and caregivers navigating this diagnosis for their child, though the condition can also affect adults.

RALD is an “ALPS-like” disorder, meaning it mimics many features of the more common Autoimmune Lymphoproliferative Syndrome but is driven by a different biological mechanism. In RALD, specific genes that control cell growth, known as NRAS or KRAS, develop a “stuck switch” that tells certain white blood cells to survive and multiply when they should naturally die off ^[1]. Because these are somatic mutations, they occur by chance in the blood-forming cells; they are generally not inherited from parents, and siblings are not expected to share the acquired mutation ^[2].

The behavior of RALD is generally considered indolent, or slow-moving, but it requires careful attention because of how these overactive cells affect the body. While evidence is based on very small, selected case series and cannot predict an individual child’s course, the most common physical signs include an enlarged spleen and liver, as well as swollen lymph nodes, as the body’s filtering system becomes crowded with excess immune cells ^[3]. Internally, the immune system may become confused and begin attacking the body’s own healthy blood cells, a process called autoimmunity that can lead to low red blood cell or platelet counts ^[4]. While many children remain stable for long periods, the presence of these specific genetic mutations necessitates lifelong surveillance by an expert team to monitor for rare instances where the disease might progress into more aggressive blood conditions ^[1].

Managing RALD is a marathon of active surveillance and manifestation-driven care. Treatment is not always continuous; instead, doctors intervene when specific symptoms, like severe anemia or significant organ swelling, impact a child’s health ^[5]. Modern care focuses on using targeted medications to quiet the immune system while avoiding procedures like splenectomy when possible, as spleen removal introduces lifelong, severe infection risks ^[6]. By building a dedicated team of specialists and maintaining a clear emergency action plan, families can navigate the complexities of this rare diagnosis with a focus on preserving long-term health and quality of life ^[7].